TrialStatistical methods in medical research2022

A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy.

Beibei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.